V600E and additional mutations activate signalling pathways such as mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinases (ERK)6 that potentiate phenomena related to tumour invasiveness such as the secretion of metalloproteinases (MMPs)11, cell differentiation and angiogenesis22. The gene discussed is MAP2K7; the disease is neoplasm.